Sign In

Brinda Balakrishnan

Group Vice President, Corporate and Business Development at BioMarin Pharmaceutical Inc.

Brinda Balakrishnan is a corporate strategist and deal maker with a unique blend of business acumen and a physician-scientist perspective. She is dedicated to advancing impactful medicines through value creation and risk stratification for patients.

She has a proven track record of leading inorganic growth strategies, expanding R&D portfolios, and executing various transactions including M&A, licensing, and research collaborations across a wide range of assets from preclinical to commercial stages and multiple modalities.

Brinda has expertise in sell-side transactions for preclinical, clinical, and commercial assets, as well as in private financing activities, resulting in non-dilutive and venture financing for the organizations she has been a part of.

Engaging regularly with boards of directors, she plays a pivotal role in shaping corporate strategy and driving business development transactions to achieve organizational goals.

Educationally, Brinda holds an S.B. in Chemical Engineering, a PhD in Biomedical Engineering and Chemical Engineering, as well as an MD-PhD in Medicine and Biomedical Engineering from prestigious institutions such as Massachusetts Institute of Technology and Harvard Medical School.

With a rich professional background, Brinda Balakrishnan has held key positions such as Group Vice President of Corporate and Business Development at BioMarin Pharmaceutical Inc., Vice President of Product Development and Corporate Strategy at Vision Medicines, and various roles in renowned organizations like McKinsey & Company, Genzyme, Beth Israel Deaconess Medical Center, and others.

Her experience spans from resident physician and biomedical engineer to business development and consulting roles, showcasing her versatile skill set and comprehensive understanding of the pharmaceutical and healthcare industries.

Brinda Balakrishnan
Add to my network

Location

San Francisco Bay Area